Skip to content
sellWeak cluster of 2

Shane Ward sold $37k of CDTX

COO & CLO at Cidara Therapeutics, Inc.. 1,664 shares at an average of $21.96, traded Mar 11, 2025, filed Mar 13, 2025.

Warning score
39
Value
$37k
1,664 shares
Holdings after
14,674
-10% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    COO
    +20
  • Trade size
    $37k at market
    +6
  • Share of holdings sold
    Sold 10% of holdings
    +5
  • Cluster
    2 insiders selling within 14 days
    +8

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0001610618-25-000024, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Mar 11, 2025SOpen-market sale
Common Stock
-1,664$21.96$37k14,674Mar 13, 2025

Related signals

Other insiders at Cidara Therapeutics, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
20Weak
CDTXsell
Cidara Therapeutics, Inc.
Nicole Negar Davarpanah
Chief Medical Officer
$30k
474 shares
-1%
50Moderate
CDTXbuy
Cidara Therapeutics, Inc.
Ra Capital Management, L.p.
director, owner
$100M
2,272,727 shares
+208%
31Weak
CDTXbuy
Cidara Therapeutics, Inc.
Chrysa Mineo
director
$74k
3,320 shares
-
29Weak
CDTXsell 2
Cidara Therapeutics, Inc.
Leslie Tari
CHIEF SCIENTIFIC OFFICER
$39k
1,773 shares
-10%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Shane Ward sold $37k of CDTX | InsiderTell